Amot130 adapts atrophin-1 interacting protein 4 to inhibit yes-associated protein signaling and cell growth.
about
Regulation of localization and function of the transcriptional co-activator YAP by angiomotin.Angiomotins link F-actin architecture to Hippo pathway signaling.The role of angiomotin phosphorylation in the Hippo pathway during preimplantation mouse development.Energy stress regulates hippo-YAP signaling involving AMPK-mediated regulation of angiomotin-like 1 protein.Deubiquitylating enzyme USP9x regulates hippo pathway activity by controlling angiomotin protein turnoverThe ubiquitin E3 ligase ITCH enhances breast tumor progression by inhibiting the Hippo tumor suppressor pathway.Angiomotin is a novel component of cadherin-11/β-catenin/p120 complex and is critical for cadherin-11-mediated cell migration.Ski regulates Hippo and TAZ signaling to suppress breast cancer progression.DUB3 Deubiquitylating Enzymes Regulate Hippo Pathway Activity by Regulating the Stability of ITCH, LATS and AMOT ProteinsSerum deprivation inhibits the transcriptional co-activator YAP and cell growth via phosphorylation of the 130-kDa isoform of Angiomotin by the LATS1/2 protein kinasesAngiomotin regulates prostate cancer cell proliferation by signaling through the Hippo-YAP pathway.Angiomotin'g YAP into the nucleus for cell proliferation and cancer development.The Angiomotins--from discovery to function.The E3 ligase Itch in immune regulation and beyond.The hippo tumor suppressor network: from organ size control to stem cells and cancer.Yap reprograms glutamine metabolism to increase nucleotide biosynthesis and enable liver growthLow angiomotin-p130 with concomitant high Yes-associated protein 1 expression is associated with adverse prognosis of advanced gastric cancer.The physiological role of Motin family and its dysregulation in tumorigenesis.Ubiquitin-Dependent Regulation of the Mammalian Hippo Pathway: Therapeutic Implications for Cancer.
P2860
Q30352874-F8B18BEF-644F-4989-9DC8-732D6F9A9117Q33604410-B4478C95-B5FC-43C2-B799-EF7BD75E85D2Q34420716-BF18A140-BDE1-4A16-BDE2-5C5D2BBFAFD3Q34469155-D637AE97-934E-4E10-8052-2A6E273974D9Q34535458-C3E8C442-4FAA-4EC4-A392-A3CCDE2871F9Q34786592-17869A10-07D4-458C-AAC9-F589D20932DCQ35576534-B5485C61-AC47-484B-9487-57F4A98F7D93Q35688452-A7471FBE-7A06-4696-9BCB-E93B064EFFECQ36243011-06D72B43-919E-4CC3-8C07-EDA45CD9E282Q37255948-E1ECF102-581C-434F-A3CA-0F3DEDE55EE1Q37705796-BAF6AB36-9B4D-487C-9656-8F6D7184D2DEQ38134067-6D7EDD78-1402-4A32-A0BD-132E1D6B420AQ38189166-F5DD4226-CCC9-475C-A013-905E45B5DF0BQ38530613-4114536E-BBA3-4387-96E2-0C6FBF534958Q39869336-775FEDEE-1D1F-47DF-A01E-E1492028F8AFQ41665542-74A7AEB3-5456-4F86-95D1-07E680F2B03BQ47834790-905E7263-E323-44E9-83A0-92AA8AE60F0CQ52591394-FDB70628-452B-4B21-931A-A24A7EC2E741Q54973587-66D7F2E9-470B-434D-A7DE-A33AC0C28D8B
P2860
Amot130 adapts atrophin-1 interacting protein 4 to inhibit yes-associated protein signaling and cell growth.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Amot130 adapts atrophin-1 inte ...... ein signaling and cell growth.
@en
type
label
Amot130 adapts atrophin-1 inte ...... ein signaling and cell growth.
@en
prefLabel
Amot130 adapts atrophin-1 inte ...... ein signaling and cell growth.
@en
P2093
P2860
P356
P1476
Amot130 adapts atrophin-1 inte ...... ein signaling and cell growth.
@en
P2093
Brigitte L Heller
Clark D Wells
Hyun-Suk Lim
Jacob J Adler
Lauren R Bringman
Mark G Goebl
Robert J Ingham
Ross R Cocklin
William P Ranahan
P2860
P304
15181-15193
P356
10.1074/JBC.M112.446534
P407
P577
2013-04-05T00:00:00Z